SherpaBonds
US78081BAQ68 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 5.15% 2029/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
102.59
par = 100
YIELD TO MAT.
4.60%
semi-annual
COUPON
5.150%
semi-annual · fixed
MATURITY
2029-09-02
bullet · 3.32y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
3.00 y
1bp ↑ ≈ -0.030% P&L
Convexity
10.92
higher = more curvature
Years to maturity
3.32 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares iBonds Dec 2029 Term Corporate
iShares
iBonds 2029 Corporate$3.9M▼ $5K0.10%2026-05-07
iShares 1-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate 1-5Y$3.7M▼ $2K0.02%2026-05-07
Invesco BulletShares 2029 Corporate Bond
Invesco
BulletShares 2029 Corporate$3.5M▲ $5K0.12%2026-05-05
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$3.4M▼ $4K0.00%2026-05-07
Vanguard Total Bond Market
Vanguard
US Aggregate$3.1M—0.00%2026-03-31
Vanguard Short-Term Bond
Vanguard
US Aggregate Short$1.2M—0.00%2026-03-31
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.2M▼ $7330.01%2026-05-07
Vanguard Short-Term Corporate Bond
Vanguard
US Corporate Short$1.1M—0.00%2026-03-31
iShares Core Universal USD Bond
iShares
US Aggregate$605K▼ $7930.00%2026-05-07
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$508K▲ $4300.00%2026-05-05
iShares 0-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate$462K▼ $5780.02%2026-05-07
iShares Core 1-5 Year USD Bond
iShares
US Short-Term Core$236K▼ $3090.01%2026-05-07
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$164K▼ $2150.00%2026-05-07
iShares ESG Advanced Universal USD Bond
iShares
US Aggregate$46K▼ $600.01%2026-05-07
iShares iBonds 1-5 Year Corporate Ladder
iShares
iBonds Corporate$16K—0.02%2026-05-06
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$122—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

45/ 100Active coverage
Interpretation. Light institutional footprint, with net distribution
HOLDERS
16
▲ 3 signals in 7d
AGGREGATE EXPOSURE
$23.1M
USD across all
TOP CONCENTRATION
16.9%
largest holder
FLOW
▼ $2.9M
▲ 3 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
102,589 USD
PRICE
102.59

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 5.15 09/02/29
FIGI
BBG01N5DKQV0
CUSIP
78081BAQ6
ISIN
US78081BAQ68
Type
Corp
Issued
2024-06-10
Face value
100 USD
Ticker
RPRX 5.15 09/02/29
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 2.2% 09/2030
Royalty Pharma Plc
2030-09
4.68%
+8 bps yield+1y duration9 signals in commonSame issuer
Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.73%
+13 bps yield+2y duration7 signals in commonSame issuer
Royalty Pharma Plc 1.75% 09/2027
Royalty Pharma Plc
2027-09
4.44%
−16 bps yield−2y duration9 signals in commonSame issuer
Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.79%
+19 bps yield+2y duration6 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+68 bps yield+6y duration6 signals in commonSame issuer
Royalty Pharma Plc 5.4% 09/2034
Royalty Pharma Plc
2034-09
5.20%
+60 bps yield+5y duration5 signals in commonSame issuer